The Dermatology CRO market was valued at $5,007.7 Million in 2022, and is projected to reach $8,228.7 Million by 2031 growing at a CAGR of 5.72% from 2023 to 2031. Clinical segment is expected to be the highest contributor to this market, with $4,032.9 Million in 2022, and is anticipated to reach $6,349.5 Million by 2031, registering a CAGR of 5.22%. Drug Discovery segment is anticipated to reach $886.9 Million by 2031 with the highest CAGR of 8.13%. Clinical and Preclinical segments collectively expected to account for about 91.2% share of the Dermatology CRO market in 2022, with the former constituting around 80.5% share. Drug Discovery and Preclinical segments are expected to witness significant growth rates at a CAGR of 8.13% and 7.13% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 19.5% in the overall Dermatology CRO market in 2022, and is anticipated to reach 22.8% by 2031.
1. Global Dermatology CRO Market, By Type
1.1. Overview
1.2. Drug Discovery
1.2.1 Drug Discovery Market, By Region
1.2.1.1 North America Drug Discovery Market, By Country
1.2.1.2 Europe Drug Discovery Market, By Country
1.2.1.3 Asia-Pacific Drug Discovery Market, By Country
1.2.1.4 Rest of World Drug Discovery Market, By Country
1.3. Preclinical
1.3.1 Preclinical Market, By Region
1.3.1.1 North America Preclinical Market, By Country
1.3.1.2 Europe Preclinical Market, By Country
1.3.1.3 Asia-Pacific Preclinical Market, By Country
1.3.1.4 Rest of World Preclinical Market, By Country